abstract |
PROBLEM TO BE SOLVED: To provide a new protein that can be used for angiogenesis therapy. SOLUTION: A fusion polypeptide containing a cell membrane penetrating peptide, a DNA binding peptide that binds to the base sequence of an ETV2 (ETS variant 2) gene, and a transcriptional activator. [Selection diagram] None |